Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

GeneDx Holdings Corp. - Class A Common Stock (NQ:WGS)

61.91 +0.92 (+1.51%)

Streaming Delayed Price Updated: 10:29 AM EDT, Jun 12, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	431,178
Open	62.22
Bid (Size)	61.56 (100)
Ask (Size)	62.17 (100)
Prev. Close	60.99
Today's Range	60.04 - 63.31
52wk Range	32.21 - 170.87
Shares Outstanding	N/A
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

WGS INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds GeneDx (WGS) Investors of Securities Class Action Lawsuit Deadline on August 3, 2026

Today 10:05 EDT

From Faruqi & Faruqi LLP

Via GlobeNewswire

GeneDx Holdings Securities Fraud Class Action Result of Acquisition Performance Misrepresentations and 49% Stock Decline - Investors May Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC

June 11, 2026

New York, New York and New Orleans, Louisiana--(Newsfile Corp. - June 11, 2026) - Kahn Swick & Foti, LLC ("KSF")...

Via Newsfile

Performance

YTD	-53.2%	-53.2%
1 Month	+56.8%	+56.8%
3 Month	-19.4%	-19.4%
6 Month	-60.2%	-60.2%
1 Year	-12.0%	-12.0%

More News

ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages GeneDx Holdings Corp. Investors to Secure Counsel Before Important Deadline in Securities Class Action - WGS

June 11, 2026

From The Rosen Law Firm PA

Via GlobeNewswire

Hedge Funder Eli Casdin Is Loading up on GeneDx Shares ↗

June 11, 2026

Via The Motley Fool

GeneDx Holdings Securities Fraud Class Action Result of Acquisition Performance Misrepresentations and 49% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC

June 11, 2026

From SkyMedia, LLC

Via GlobeNewswire

WGS INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that GeneDx Holdings Corp. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

June 11, 2026

From Robbins Geller Rudman & Dowd LLP

Via Business Wire

GeneDx Holdings Securities Fraud Class Action Result of Acquisition Performance Misrepresentations and 49% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC

June 10, 2026

Via Newsfile

GENEDX HOLDINGS CORP. (WGS) INVESTOR ALERT Investors With Large Losses in GeneDe Holdings Corp. Should Contact Bernstein Liebhard LLP To Discuss Their Rights

June 10, 2026

From Bernstein Liebhard LLP

Via GlobeNewswire

GeneDx Holdings Securities Fraud Class Action Result of Acquisition Performance Misrepresentations and 49% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC

June 09, 2026

From Kahn Swick & Foti, LLC

Via GlobeNewswire

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in GeneDx Holdings Corp. of Class Action Lawsuit and Upcoming Deadlines – WGS

June 09, 2026

From Pomerantz LLP

Via GlobeNewswire

WGS Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in GeneDx Holdings Corp. Securities Lawsuit - Contact Levi & Korsinsky

June 09, 2026

From Levi & Korsinsky, LLP

Via Business Wire

GeneDx Holdings Securities Fraud Class Action Result of Acquisition Performance Misrepresentations and 49% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC

June 09, 2026

Via Newsfile

WGS Investors Have Opportunity to Lead GeneDx Holdings Corp. Securities Fraud Lawsuit with the Schall Law Firm

June 09, 2026

From Schall Law

Via GlobeNewswire

Important Notice to Long-Term Shareholders of Badger Meter, Inc. (NYSE: BMI); GeneDx Holdings Corp. (NASDAQ: WGS); GRAIL, Inc. (NASDAQ: GRAL); and Verra Mobility Corporation (NASDAQ: VRRM): Grabar Law Office is Investigating Claims on Your Behalf

June 09, 2026

From Grabar Law Office

Via GlobeNewswire

GeneDx Holdings Securities Fraud Class Action Result of Acquisition Performance Misrepresentations and 49% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC

June 08, 2026

From Kahn Swick & Foti, LLC

Via Business Wire

Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against GeneDx Holdings Corp. and Encourages Investors to Contact the Firm

June 08, 2026

From Bragar Eagel & Squire

Via GlobeNewswire

From Industry Titans to Tiny Fish: 3 Key Stocks Insiders are Trading ↗

June 06, 2026

Via MarketBeat

Rosen Law Firm Urges GeneDx Holdings Corp. (NASDAQ: WGS) Stockholders to Contact the Firm for Information About Their Rights

June 05, 2026

From Rosen Law Firm

Via Business Wire

WGS Investors Have Opportunity to Lead GeneDx Holdings Corp. Securities Fraud Lawsuit with the Schall Law Firm

June 05, 2026

From The Schall Law Firm

Via Business Wire

Investor Notice: Robbins LLP Informs Investors of the GeneDx Holdings Corp. Class Action Lawsuit

June 04, 2026

From Robbins LLP

Via Business Wire

DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds GeneDx (WGS) Investors of Securities Class Action Deadline on August 3, 2026

June 04, 2026

From Faruqi & Faruqi, LLP

Via Business Wire

GeneDx to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference

May 26, 2026

From GeneDx

Via Business Wire

This Healthcare Investor Added $43 Million to a Genomics Leader Growing Volume 34% ↗

May 23, 2026

Via The Motley Fool

Is GeneDx Stock a Buys After a Company Director Purchased Over 350,000 Shares? ↗

May 21, 2026

Via The Motley Fool

Bragar Eagel & Squire, P.C. is Investigating GeneDx Holdings Corp. (NASDAQ:WGS) on Behalf of GeneDx Stockholders and Encourages Investors with Losses to Contact the Firm

May 19, 2026

From Bragar Eagel & Squire

Via GlobeNewswire

Frequently Asked Questions

Is GeneDx Holdings Corp. - Class A Common Stock publicly traded?

Yes, GeneDx Holdings Corp. - Class A Common Stock is publicly traded.

What exchange does GeneDx Holdings Corp. - Class A Common Stock trade on?

GeneDx Holdings Corp. - Class A Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for GeneDx Holdings Corp. - Class A Common Stock?

The ticker symbol for GeneDx Holdings Corp. - Class A Common Stock is WGS on the Nasdaq Stock Market

What is the current price of GeneDx Holdings Corp. - Class A Common Stock?

The current price of GeneDx Holdings Corp. - Class A Common Stock is 61.91

When was GeneDx Holdings Corp. - Class A Common Stock last traded?

The last trade of GeneDx Holdings Corp. - Class A Common Stock was at 06/12/26 10:29 AM ET

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.